- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Ribon Therapeutics cribs $65m
Osage University Partners has returned to back the cancer and inflammatory drug developer based on research from multiple universities.
Jul 19, 2021Daily Deal Round Up: July 19, 2021
Debt repayment platform developer InDebted received $18.4m from investors including MassMutual, while corporate-backed AdaptiveMobile, Immersal and Pocket Casts are all being acquired.
Jul 19, 2021Aurora shines in $13bn reverse merger
Paccar, Uber and Volvo Group are taking part in a $1bn PIPE supporting the autonomous driving technology developer’s reverse merger with Reinvent Technology Partners.
Jul 19, 2021Blend Labs lands on NYSE in $360m IPO
The Salesforce-backed banking software producer floated at the top of its range and saw its shares rise on their first day of trading.
Jul 19, 2021Lenskart to leverage $220m in funding
Temasek and Falcon Edge Capital co-led a late-stage round for the SoftBank-backed eyewear retailer valuing it at $2.5bn.
Jul 19, 2021Mei Wei makes off with over $155m
New Hope Group was among the participants in the dental clinic franchise owner's series B round, which lifted its overall funding past $200m.
Jul 19, 2021Genvid generates $113m series C round
Samsung, NTT Docomo and Huya helped the livestreaming technology provider close a round that took its overall funding to $166m.
Jul 19, 2021TScan takes in $100m through IPO
The Alphabet, Astellas, Novartis and WuXi AppTec-backed cancer therapy developer priced its shares at the foot of their range in an upsized offering.
Jul 19, 2021OM1 turns to Kaiser Permanente in $85m round
Kaiser Permanente co-led the medical data software provider's latest round, pushing its total funding past the $170m mark.
Jul 19, 2021Wugen wraps up $172m series B
WUSTL spinout Wugen has collected $172m in a series B round to progress its pipeline targeting several cancer indications.
Jul 19, 2021Ribon Therapeutics cribs $65m
Johnson & Johnson, Novartis and Takeda returned to back the cancer and inflammatory drug developer and were joined by investors including AbbVie, Alphabet and Bristol Myers Squibb.
Jul 19, 2021YuLife livens up with $70m
Target Global led the RGA-backed gamified life insurance platform’s series B round, which valued it at almost $350m.
Jul 19, 2021Featured Content
GCV Powerlist 2026Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.GCV Powerlist 2026
Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
Corporate venture building reportData from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomesCorporate venture building report
Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


